Novo Nordisk CEO to face off with Bernie Sanders over 1300% Ozempic markup in U.S. - Fortune


6/17/2024

Novo Nordisk CEO to face off with Bernie Sanders over 1300% Ozempic markup in U.S.  FortuneNovo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy  Reuters.comSanders drops subpoena effort after Novo Nordisk CEO agrees to testify  The HillBernie Sanders will grill Novo Nordisk's CEO over Ozempic prices  QuartzBernie Sanders to grill Novo Nordisk CEO on cost of Ozempic and Wegovy  Business Insider...

Original

Tags: agrees | ceo | drops | face | high | insider | ozempic | senate | u.s.



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top